Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain

Adriana Palom, Edurne Almandoz, Antonio Madejón, Ariadna Rando-Segura, Ylenia Pérez-Castaño, Judit Vico, Sara Gándara, Naranbaatar Battulga, Jordi Gómez-I-Prat, Mar Riveiro-Barciela, Juan Arenas Ruiz-Tapiador, Javier García-Samaniego, Maria Buti*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review


Mongolia has one of the highest viral hepatitis infection (B, C, and D) rates in the world. The aims of this study were to increase awareness of this disease and promote viral hepatitis screening in the Mongolian community living in Spain. Through a native community worker, Mongolian adults were invited to a community program consisting of an educational activity, an epidemiological questionnaire, and rapid point-of-care testing for hepatitis B and C. In those testing positive, blood extraction was performed to determine serological and virological parameters. In total, 280 Mongolians were invited to the program and 222 (79%) attended the event: 139 were women (63%), mean age was 42 years, and 78 (35%) had viral hepatitis risk factors. Testing found 13 (5.8%) anti-HCV-positive individuals, 1 with detectable HCV RNA (0.5%), 8 HBsAg-positive (3.6%), and 7 with detectable HBV DNA (3.1%). One additional individual had HBV/HCV co-infection with detectable HBV DNA and HCV RNA. Two subjects had hepatitis B/D co-infection (0.9%). The knowledge questionnaire showed a 1.64/8-point (20.5%) increase in correct answers after the educational activity. In summary, a viral hepatitis community program was feasible and widely accepted. It increased awareness of this condition in the Mongolian community in Spain and led to linkage to care in 22 participants, 50% of whom were unaware of their infection.

Original languageEnglish
Article number1506
Number of pages7
Issue number7
Publication statusPublished - 5 Jul 2023


  • Community program
  • Mongolian community
  • Viral hepatitis awareness
  • Viral hepatitis screening

Cite this